Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Comparative Effectiveness Trial of Sublingual Versus Extended-release Buprenorphine With Individuals Leaving a Carceral Setting

NCT06306443 is registered in ClinicalTrials.gov with Friends Research Institute, Inc. as lead sponsor.

NCT NCT06306443
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06306443 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Comparative Effectiveness Trial of Sublingual Versus Extended-release Buprenorphine With Individuals Leaving a Carceral Setting
Lead sponsor
Friends Research Institute, Inc.
Phase
Phase 3
Overall status
Recruiting
Start date
June 20, 2025
Completion date
April 30, 2029
Enrollment
240 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

opioid use disorder